Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
QURE · against 398 other Healthcare companies of similar size
Ranked #301 of 399 · scores higher than 23% of peers
Bars: peers in each 10-point band of the growth score53 peers with a growth score of 20–29, including QURE · Click a bar to see the companies
Mainly because of its 3-year revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
| Metric | QURE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 402 reported | 30.2% | 6.2% | 87% | 33% | |
| Earnings per share growthHigher is better · 221 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 391 reported | -45.0% | 6.9% | 2% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 2.8B USD | 99 | 51 | |
| 301 | 12.1B CNY (≈$1.7B) | 25 | 15 | |
| 301 | 174.8B JPY (≈$1.2B) | 25 | 45 | |
| 301 | 18.8B CNY (≈$2.6B) | 25 | 68 | |
| 301 | 2.3B USD | 25 | 52 | |
| 301 | 1.7B USD | 25 | 30 | |
| 301 | 15.6B SEK (≈$1.6B) | 25 | 42 | |
| 309 | 7.4B CNY (≈$1.0B) | 24 | 34 | |
| 309 | 13.4B CNY (≈$1.9B) | 24 | 43 | |
| 309 | 9.7B SEK (≈$965M) | 24 | 45 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score